Having another read over the presentation, gross revenue grew by 2% which means negative organic growth excluding the new CSP. That was probably the worrying figure in H1.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025